PCI-SIG, the trade group for the PCIe interface that is used in computer peripheral boards and increasingly is being used as a more general communication and storage interface announced a low power capability to support high speed interfaces for...
CAMBRIDGE, MA -- (Marketwire) -- 06/14/12 -- Molecular Insight Pharmaceuticals, Inc. today announced the presentation of nonclinical and clinical data at the Society of Nuclear Medicine 2012 Annual Meeting held June 9-13 in Miami Beach, Florida. The
CAMBRIDGE, MA -- (Marketwire) -- 02/02/12 -- Molecular Insight Pharmaceuticals, Inc. (MIP) will present first human data on the molecular imaging of metastatic prostate cancer in bone and soft tissue with their new 99mTc-radiolabeled compounds. The
HAMILTON, ON and CAMBRIDGE, MA -- (Marketwire) -- 01/30/12 -- A new targeted radiopharmaceutical, designed to deliver a therapeutic dose of radiation directly to metastatic prostate cancer, will be manufactured in Hamilton, Ontario to be used in
Programmable radio frequency (RF) MEMS chip specialist WiSpry Inc. (Irvine, Calif.) has announced the introduction to the market of the WS2018 antenna tuning component. The WS2018 is designed to sit between the antenna and the RF front-end module...
CAMBRIDGE, MA -- (Marketwire) -- 05/06/11 -- Molecular Insight Pharmaceuticals, Inc. (OTCQB: MIPIQ) (PINKSHEETS: MIPIQ), today announced that at a hearing held on May 5, 2011, the U.S. Bankruptcy Court for the District of Massachusetts confirmed the
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to Molecular Insight Pharmaceuticals (MIPI):